Key facts
- This page summarizes Malik Y. Kahook's Form 3 filing for SpyGlass Pharma, Inc. (SGP).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 05 Feb 2026, 13:01.
Malik Y. Kahook - 05 Feb 2026 Form 3 Insider Report for SpyGlass Pharma, Inc. (SGP)
- Reporting relationship
- President, Chief Medical Officer, Executive Chair Exhibit 24 - Power of Attorney, Director
- Issuer ticker
- SGP
- Reported as of
- 05 Feb 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Brian Aukshunas. as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Malik Y. Kahook filed Form 3 for SpyGlass Pharma, Inc. (SGP) on 05 Feb 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002106409
Primary reporting owner
Kahook Malik Y.
- Relationship
- President, Chief Medical Officer, Executive Chair Exhibit 24 - Power of Attorney, Director
- Address
- C/O SPYGLASS PHARMA, INC., 27061 ALISO CREEK RD., SUITE 100, ALISO VIEJO
- Signature
- /s/ Brian Aukshunas. as Attorney-in-Fact
- Signature date
- 05 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 873,978
- Date
- 05 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SGP
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 72,389
- Exercise price
- $2.18
- Footnotes
- F1
SGP
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 191,874
- Exercise price
- $2.87
- Footnotes
- F2
SGP
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 170,475
- Exercise price
- $7.11
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean October 6, 2023.
Footnote F2
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 20, 2025.
Footnote F3
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 30, 2025.
SEC remarks
President, Chief Medical Officer, Executive Chair Exhibit 24 - Power of Attorney